The Translational Neuropharmacology Lab is proud to announce that Dr. Apostolakis delivered a compelling presentation at the 19th European Congress of Psychology, held July 1-4, 2025, in Paphos, Cyprus. His research presentation, “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” highlighted groundbreaking findings in the field of smoking […]

Read More »

We are excited to announce that Dr. Zanos, the Director of the Translational Neuropharmacology Laboratory, has been honored with the prestigious 2025 Research Excellence Award from the University of Cyprus. The award, presented by the Minister of Education of Cyprus on June 25, 2025, recognizes Dr. Zanos’ and our lab’s groundbreaking contributions to neuroscience and […]

Read More »

We’re excited to share a special moment from the 10th Mediterranean Neuroscience Society Conference 2025 in Crete, Greece. Our lab director had the incredible opportunity to meet Professor George Paxinos AO, one of the most influential figures in modern neuroscience. Professor Paxinos is universally recognized as “the man who mapped the brain.” He’s the author […]

Read More »

Dr. Panos Zanos represented our lab at the Mediterranean Neuroscience Society Conference in Crete, where he chaired a symposium on ketamine’s rapid antidepressant mechanisms. The symposium, titled “Unraveling ketamine’s rapid antidepressant mechanisms: From neural circuits to clinical implications,” brought together leading researchers from around the world to discuss cutting-edge findings on how ketamine works as […]

Read More »

Dr. Michael (Marie Curie fellow from our lab) presented new research at the Mediterranean Neuroscience Society Conference in Crete, showcasing our latest findings on how a ketamine metabolite could help treat opioid addiction. Her poster focused on (2R,6R)-hydroxynorketamine (HNK), a ketamine metabolite, and its effects on opioid addiction-related behaviors in mice. The research tackled one […]

Read More »

Dr. Panos Zanos delivered an engaging discussion on “Social Media & Brain” as part of the 37th Pan-Cypriot Festival of Youth and Students. The talk explored the fascinating intersection between our digital habits and neurological processes, including insights from current research on how social media platforms influence brain function, potentially covering topics such as dopamine reward […]

Read More »

The Zanos Lab is delighted to share that Dr. Polymnia Louka, our Marie Skłodowska-Curie Fellow, delivered an engaging talk at the European University Cyprus (EUC) Annual Conference. Invited to address students and faculty, Dr. Louka discussed her journey to securing the prestigious and competitive Marie Curie Fellowship, as well as her innovative research exploring the […]

Read More »

We are pleased to announce that the Zanos Lab at the University of Cyprus is an integral part of the newly awarded COST Action “PSY-NET: Psychedelic renaissance: turn on, tune in and drop in” (OC-2024-1-27517). This collaborative network brings together 83 leading researchers from 21 European countries to advance psychedelic research across multiple disciplines. The […]

Read More »

The Zanos Lab is pleased to announce that Dr. Apostolakis has presented research at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” addressed a critical challenge in smoking cessation efforts. Nicotine addiction is characterized by high […]

Read More »

We are pleased to announce that Dr. Panos Zanos, Director of the Zanos Lab at the University of Cyprus, recently delivered a lecture as part of the prestigious Neuroscience Lecture Series (NLS) at the University of Bern, Switzerland, for the 2024/25 academic year. Dr. Zanos presented the lab’s cutting-edge research on ketamine’s antidepressant properties, challenging […]

Read More »